| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 73801 |
脂质体包裹噬菌体ABSZ6（LIP-ABSZ6），载药脂质体定制服务 |
207 |
axc |
2024-12-18 |
| 73802 |
DOTA-3G3-dimer DOTA-3G3-二聚体 |
66 |
h |
2024-12-18 |
| 73803 |
CAS: 1884578-27-1 Alloc-Val-Ala-PAB-PNP |
72 |
WYQ |
2024-12-18 |
| 73804 |
cas:646502-53-6 ，MC-Val-Cit-PAB-MMAE，VCMMAE 单甲基奥瑞他汀E |
83 |
kx |
2024-12-18 |
| 73805 |
布地奈德脂质体,Budesonide,liposomes,BUD-LNPs,靶向脂质体定制服务 |
84 |
axc |
2024-12-18 |
| 73806 |
DOTA-Lys-PEG4-[D-Phe6,Sta13]-BN(6-14)NH2(HZ219)DOTA缀合的GRPr拮抗剂 |
67 |
h |
2024-12-18 |
| 73807 |
[131I]SIB-PEG4-CHC 聚乙二醇化秋水仙素衍生物-定制 |
113 |
zyl |
2024-12-18 |
| 73808 |
PEG-G5.NH2-FITC-DOTA(Gd)-Monalizumab/IPH4301纳米探针 |
64 |
h |
2024-12-18 |
| 73809 |
虾青素脂质体，提供荧光脂质体定制服务 |
90 |
axc |
2024-12-18 |
| 73810 |
PEG2-D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2；peg2-RM26-科研定制 |
127 |
zyl |
2024-12-18 |
| 73811 |
DOTA-PEG(4)-[D-Phe(6) |
65 |
h |
2024-12-18 |
| 73812 |
Azide-PEG3-Val-Cit-PAB-MMAF，叠氮-三聚乙二醇-VAL-CIT-PAB-MMAF |
62 |
kx |
2024-12-18 |
| 73813 |
DOTA-3G(3)-dimer DOTA-3G(3)-二聚体 |
84 |
h |
2024-12-18 |
| 73814 |
HS-(CH2)11-triphenylimidazole；HS-(CH2)11-三苯基咪唑 |
89 |
zyl |
2024-12-18 |
| 73815 |
雷公藤甲素脂质体,1-Lips,脂质体纳米载体定制服务 |
78 |
axc |
2024-12-18 |
| 73816 |
DOTAGA-PEG(2)-RM26 DOTA修饰铃蟾肽衍生的GRPR拮抗剂PEG(2)-RM26 |
86 |
h |
2024-12-18 |
| 73817 |
cas:159857-79-1，Val-Cit-PAB，ADC定制 |
56 |
wyh |
2024-12-18 |
| 73818 |
2529982-76-9，Azido-PEG4-Val-Ala-PAB，叠氮-四聚乙二醇-VAL-ALA-PAB |
79 |
kx |
2024-12-18 |
| 73819 |
DOTA-PEG11-Tz DOTA-PEG11-四嗪 |
90 |
h |
2024-12-18 |
| 73820 |
阿霉素-卡铂脂质体,doxorubicin-carboplatin,liposome,DOX/CBP-Lip,多功能载药脂质体定制服务 |
81 |
axc |
2024-12-18 |
| 73821 |
HS(CH2)11OH烷基链定制 |
72 |
zyl |
2024-12-18 |
| 73822 |
NH(2)-PEG-DOTA-PEG-NH(2)-GQDs NH2-PEG-DOTA-PEG-NH2偶联羧基化石墨烯量子点 |
87 |
h |
2024-12-18 |
| 73823 |
Fmoc-Val-Cit-PAB-PNP（CAS:863971-53-3） |
61 |
WYQ |
2024-12-18 |
| 73824 |
Au23(S-c-C6H11)16 烷基链定制 |
73 |
zyl |
2024-12-18 |
| 73825 |
DOTA-PEG-OPSS-AuNP 邻吡啶基二硫化物-聚乙二醇-金属螯合剂DOTA修饰30纳米金纳米粒子(AuNP) |
74 |
h |
2024-12-18 |
| 73826 |
壳聚糖修饰芹菜素脂质体,CS-AP-L,载药脂质体定制服务 |
92 |
axc |
2024-12-18 |
| 73827 |
DBCO-PEG4-Val-Ala-PAB-PNP，二苯并环辛炔-四聚乙二醇-VAL-ALA-PAB-PNP |
58 |
kx |
2024-12-18 |
| 73828 |
cas:2412924-07-1，Py-MPB-amino-C3-PBD，ADC定制 |
61 |
wyh |
2024-12-18 |
| 73829 |
DOTA偶联胃泌素释放肽受体(GRP-R)配体 |
101 |
h |
2024-12-18 |
| 73830 |
HS(CH2)11(OCH2-CH2)6OCH2CO2H |
77 |
zyl |
2024-12-18 |
| 73831 |
芹菜素脂质体,Apigeninliposomes,AP-L,靶向脂质体定制服务 |
118 |
axc |
2024-12-18 |
| 73832 |
DOTA-diabody DOTA缀合的抗CEA双抗体 |
139 |
h |
2024-12-18 |
| 73833 |
cas:1810001-93-4，DBM-MMAF，ADC定制 |
87 |
wyh |
2024-12-18 |
| 73834 |
CH3(CH2)7COOH-CH3(CH2)7COOM (M =钠、钾、铷、铯)-定制 |
138 |
zyl |
2024-12-18 |
| 73835 |
cas:70396-18-8 ，Boc-Val-Ala-OH， ADC试剂 |
75 |
kx |
2024-12-18 |
| 73836 |
Boc-Val-Cit（CAS:870487-08-4），(S)-2-((S)-2-((叔丁氧基羰基)氨基)-3-甲基丁酰胺基)-5-脲基戊酸 |
70 |
WYQ |
2024-12-18 |
| 73837 |
213Bi-DOTA-PESIN 213Bi-DOTA-PEG(4)-铃蟾肽 |
115 |
h |
2024-12-18 |
| 73838 |
雷公藤甲素木蜡酸酯脂质体,triptolide,lignoceric,acid,ester,liposome,,TPL-LA-lip |
97 |
axc |
2024-12-18 |
| 73839 |
WR 2721 [H2N-(CH2)3-NH(CH2)2SPO3H2] |
81 |
zyl |
2024-12-18 |
| 73840 |
1228105-51-8，DM1-SMCC；SMCC-DM1，ADC定制 |
123 |
wyh |
2024-12-18 |
| 73841 |
Boc-Val-Cit-PAB（CAS:870487-09-5），分子式：C23H37N5O6 |
115 |
WYQ |
2024-12-18 |
| 73842 |
DOTA(1,4,7,10-四氮杂十二烷-N,N,N,N-四乙酸)之间的接头修饰环肽E-[c(RGDfK)]2 |
82 |
h |
2024-12-18 |
| 73843 |
Boc-Val-Ala-OH，cas:70396-18-8 ， 化合物 BOC-VAL-ALA-OH |
85 |
kx |
2024-12-18 |
| 73844 |
Boc-Val-Gly-OH （CAS: 45233-75-8） |
87 |
WYQ |
2024-12-18 |
| 73845 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)偶联超顺磁性氧化铁纳米粒子修饰叶酸 |
102 |
h |
2024-12-18 |
齐岳微信公众号
官方微信
库存查询